The letter arrived at Westminster with the practised confidence of a lobby that has learned exactly which words open doors. More than ten business groups and a trade union, writing jointly to over 400 Labour MPs, framed North Sea drilling not as an environmental trade-off but as a test of industrial nerve, invoking the language Andy Burnham has spent months building his prospective premiership around. Steel, defence, energy, food and farming: these are the sectors he has promised to safeguard as sovereign and strategic. Oil and gas lobbyists read that list and saw an opening. They were not wrong to.

What is more striking is who else should have read that list and has not yet moved. Medicines manufacturing does not appear in Burnham's stated critical sectors, despite years of warnings from within DHSC and across the life sciences industry about the fragility of active pharmaceutical ingredient supply chains, the vast majority of which now run through India and China. The pandemic exposed this once, briefly, before attention moved elsewhere. The argument OEUK is making to secure Rosebank and Jackdaw, that Britain should produce what it can rather than deepen its reliance on imports it cannot control, applies with at least equal force to the drugs the NHS dispenses every day. Nobody has yet written that letter. The logic sits there unclaimed.

This is not a case for treating pharmaceutical sovereignty as identical to energy sovereignty. The politics differ, the capital requirements differ, and the timelines to any meaningful onshoring are longer than a single parliamentary term. But the omission is instructive precisely because Burnham's reindustrialisation language is deliberately elastic. It was designed to answer a devolution and growth argument, not a health one, yet it is already being annexed by whichever sector moves fastest to claim it. Life sciences has spent years asking for a coherent industrial strategy that treats manufacturing resilience as seriously as research investment. A prime minister assembling his list of sectors that matter, in his first days in office, is precisely the moment such an ask might land, if anyone in the sector is paying attention to how the argument is being made elsewhere.

The second thread runs more directly into NHS finances. The CBI and Energy UK's warning that British electricity prices sit roughly 45 per cent above the G7 median was aimed at industrial competitiveness generally, but the NHS is itself one of the largest energy consumers in the public sector, and one bound by net zero commitments made under previous leadership that assumed a different cost trajectory. Trusts already managing capital backlogs and estate maintenance deferred for want of funding are not exempt from the same electricity cost pressure the CBI describes as an anchor on productivity. Every pound an NHS trust spends on power it did not budget for is a pound not spent on the waiting list, the workforce, or the equipment replacement programme that keeps slipping another year. If Burnham is serious about driving down the cost of electricity to help British industry compete, the NHS estate is one of the more overlooked beneficiaries of that argument, and one of the more overlooked casualties if he fails to act on it.

None of this means Burnham should simply add health to a list of protected sectors and consider the argument settled. Sovereignty claims are cheap to make and expensive to fulfil, and a premiership that tries to protect everything protects nothing with any credibility. But the discipline of his early choices, which sectors get the reindustrialisation label and which do not, will tell NHS leaders and life sciences investors something important about how seriously his government intends to treat supply chain resilience beyond the industries loud enough to write him a letter on day one.

The North Sea lobby understood the assignment. It read a new prime minister's stated priorities and translated its own interests into his language before he had even taken office. Health has the stronger underlying case for at least one strand of that argument. It has simply been slower to make it, and slowness in this instance carries a cost that will land on trust balance sheets long before anyone notices the gap in the sector list.